Expanded labeling for sacubitril/valsartan (Entresto, Novartis) to include adults with chronic heart failure (HF) with left ventricular ejection fraction (LVEF)
Read more
Home »
Empagliflozin’s HFpEF Efficacy Catalyzes Redefinition of HF
Groundbreaking results from the EMPEROR-Preserved trial did more than establish for the first time that a drug, empagliflozin, has clearly
Read more
EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough
The SGLT2 inhibitor empagliflozin achieved in EMPEROR-Preserved what no other agent could previously do: unequivocally cut the incidence of cardiovascular
Read more
‘High Normal’ Sodium, Poor Hydration Linked to Heart Failure
Having a “high normal” serum sodium level in midlife, which reflects less than optimal fluid intake, is associated with an
Read more
Heart Failure Diagnoses Often Missed in Primary Care Setting
(Reuters Health) – Many patients with heart failure are not diagnosed until they seek care in an acute setting, particularly
Read more
More Than Just a Hill of Beans: The Health Effects of Coffee
Befitting its status as one of the most commonly consumed beverages in the world, coffee has long been a topic
Read more
Older heart failure patients less likely to receive recommended treatments
Heart failure patients aged 80 and above are less likely to receive recommended therapies and dosages compared to their younger
Read more
Nutritional Support May Be Lifesaving in Heart Failure
Personalized nutritional support for adults hospitalized with chronic heart failure and deemed to be at high nutritional risk reduced the
Read more
Black Patients With Sarcoidosis Have More Systemic, CV Disease
Black patients diagnosed by dermatologists with cutaneous sarcoidosis were significantly more likely to have unrecognized systemic organ involvement than were
Read more
Medtronic Recall of Heartware HVAD Equipment Is Class I, Says FDA
The US Food and Drug Administration has declared Medtronic’s recent recall of batteries, power, and data link cables and other
Read more